...
首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Comparison of 34betaE12 and P63 in 100 Consecutive Prostate Carcinoma Diagnosed by Needle Biopsies.
【24h】

Comparison of 34betaE12 and P63 in 100 Consecutive Prostate Carcinoma Diagnosed by Needle Biopsies.

机译:通过穿刺活检诊断出的100例连续前列腺癌中34betaE12和P63的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

P63, a homologue of p53, was recently identified as a useful basal cell-specific marker. We compared the sensitivity and specificity of p63 with the widely used high-molecular-weight keratin 34betaE12 for the diagnosis of prostate carcinoma in needle biopsies. We selected 100 consecutive prostate carcinoma diagnosed by needle biopsies with an adequate number of cancerous glands on the slide. We chose 1 representative hematoxylin and eosin-stained slide from each case and gave it a Gleason score. The same paraffin block was retrieved for 34betaE12 and p63 stains. We compared staining patterns of 34betaE12 and p63 on both malignant glands and benign glands and recorded basal cell density (percentage of basal cells with positive staining in the benign glands). The cases were divided into 3 groups according to the Gleason score: 5 to 6 (31 cases), 7 (46 cases), and 8 to 10 (23 cases). In 20 cases, focal and patchy staining in a basal cell distribution in malignant glands (range, 1%-20%; mean, 6.6%) was demonstrated (19 by both stains and 1 by 34betaE12 only). In 1 case with a Gleason score of 9, the cancer cells, not the basal cells, were stained focally by p63 but not by 34betaE12. Higher-grade tumors demonstrated higher numbers of malignant glands with basal cell staining (1.65% for Gleason 7, 1.26% for Gleason 8-10, compared with 0.42% for Gleason 5-6). The overall specificity of the absence of basal cell staining in the malignant glands for 34betaE12 and p63 was 98.63% and 98.60%, respectively. In 17 cases, both stains revealed total absence of basal cell staining in some benign glands (range, 1%-10%; mean, 3.5%). The overall sensitivity in identifying basal cells in benign glands was 99.48% and 99.44% for 34beta12 and p63, respectively. Basal cell density was higher for 34betaE12 in comparison with p63 (92% vs. 87%). For diagnosing prostate carcinoma in the needle biopsies, p63 is as specific and sensitive ospitalHospital as as 34betaE12 and therefore can be used as a complementary basal cell-specific stain for 34betaE12 in difficult cases.
机译:P63是p53的同源物,最近被鉴定为有用的基础细胞特异性标志物。我们将p63与广泛使用的高分子量角蛋白34betaE12的敏感性和特异性进行了比较,以诊断穿刺活检中的前列腺癌。我们选择了100例经穿刺活检诊断为连续的前列腺癌,并在玻片上有足够数量的癌性腺。我们从每例病例中选择1个代表性的苏木精和曙红染色的玻片,并给其格里森评分。取相同的石蜡块用于34betaE12和p63染色。我们比较了34betaE12和p63在恶性腺和良性腺上的染色模式,并记录了基底细胞密度(在良性腺中呈阳性染色的基底细胞的百分比)。根据格里森评分将病例分为3组:5至6(31例),7(46例)和8至10(23例)。在20例病例中,在恶性腺的基底细胞分布中出现了局灶性和斑块状染色(范围为1%-20%;平均值为6.6%)(两种染色均为19种,仅34betaE12为1种)。在格里森评分为9的1例中,癌细胞(而不是基底细胞)被p63而非34betaE12局部染色。较高级别的肿瘤表现出较高的基底细胞染色恶性腺数量(格里森7号为1.65%,格里森8-10号为1.26%,格里森5-6号为0.42%)。对于34betaE12和p63,在恶性腺中不存在基底细胞染色的总体特异性分别为98.63%和98.60%。在17例中,两种染色均显示在某些良性腺中完全不存在基底细胞染色(范围1%-10%;平均值3.5%)。对于34beta12和p63,在良性腺中鉴定基底细胞的总体敏感性分别为99.48%和99.44%。与p63相比,34betaE12的基础细胞密度更高(92%比87%)。为了诊断穿刺活检中的前列腺癌,p63与34betaE12一样特异性和敏感的ospitalHospital,因此在困难情况下可以用作34betaE12的补充基础细胞特异性染色剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号